Literature DB >> 24182680

Infective endocarditis following percutaneous pulmonary valve replacement: diagnostic challenges and application of intra-cardiac echocardiography.

Gary Cheung1, Niels Vejlstrup, Nikolaj Ihlemann, Samer Arnous, Olaf Franzen, Henning Bundgaard, Lars Søndergaard.   

Abstract

BACKGROUND: Infective endocarditis (IE) following percutaneous pulmonary valve replacement (PPVR) with the Melody valve is rarely reported. Furthermore, there are challenges in this diagnosis; especially echocardiographic evidence of vegetation within the prosthesis may be difficult. METHOD AND RESULT: This study is a retrospective review of all patients with Melody valve implantation in a tertiary centre. Between November 2006 and November 2012, 43 procedures were performed in 42 patients (mean age 25 years, 6-67 years). At a median follow-up of 27 months (2-66 months), six patients were suspected for IE. However, repeated transthoracic echocardiography (TTE) and transesophageal echocardiography (TEE) showed no evidence of IE and the patients were diagnosed as possible cases according to the modified Duke's criteria. Two patients did not respond to antibiotic treatment and underwent intra-cardiac echocardiography (ICE), which clearly demonstrated vegetations. These two cases required surgical explantation, while the other four patients were treated medically without complications.
CONCLUSION: IE after Melody valve implantation is uncommon, but difficult to verify since TTE and TEE often cannot demonstrate vegetations inside the stent. ICE should be considered in suspected cases of IE following PPVR with negative TTE and TEE examinations in order to early tailor the best treatment for the individual patient suspected for IE.
© 2013.

Entities:  

Keywords:  Diagnosis; Infective endocarditis; Intra-cardiac echocardiography; Melody valve; Percutaneous pulmonary valve replacement

Mesh:

Year:  2013        PMID: 24182680     DOI: 10.1016/j.ijcard.2013.10.016

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  7 in total

Review 1.  Late postoperative prosthetic pulmonary valve endocarditis in a 13-year-old girl with repaired tetralogy of fallot.

Authors:  Michael C O'Brien; Kamal K Pourmoghadam; William M DeCampli
Journal:  Tex Heart Inst J       Date:  2015-06-01

2.  Percutaneous pulmonary and tricuspid valve implantations: An update.

Authors:  Robert Wagner; Ingo Daehnert; Philipp Lurz
Journal:  World J Cardiol       Date:  2015-04-26

Review 3.  Technology update: intracardiac echocardiography - a review of the literature.

Authors:  Nicola Vitulano; Vincenzo Pazzano; Gemma Pelargonio; Maria Lucia Narducci
Journal:  Med Devices (Auckl)       Date:  2015-05-27

Review 4.  Pulmonary endarteritis and endocarditis complicated with septic embolism: a case report and review of the literature.

Authors:  Arezoo Khosravi; Zohreh Rostami; Mohammad Javanbakht; Nematollah Jonaidi Jafari; Mohsen Sadeghi Ghahroudi; Mohammad Hassan Kalantar-Motamed; Ramezan Jafari; Behzad Einollahi
Journal:  BMC Infect Dis       Date:  2020-03-12       Impact factor: 3.090

5.  Acute endocarditis of a percutaneously placed pulmonary valve.

Authors:  Karthik V Ramakrishnan; Laura Olivieri; Richard A Jonas
Journal:  Ann Pediatr Cardiol       Date:  2015 Sep-Dec

6.  Infective Endocarditis After Melody Valve Implantation in the Pulmonary Position: A Systematic Review.

Authors:  Mohammad Abdelghani; Martina Nassif; Nico A Blom; Martijn S Van Mourik; Bart Straver; David R Koolbergen; Jolanda Kluin; Jan G Tijssen; Barbara J M Mulder; Berto J Bouma; Robbert J de Winter
Journal:  J Am Heart Assoc       Date:  2018-06-22       Impact factor: 5.501

7.  Surgical Treatment of Infective Endocarditis in Pulmonary Position-15 Years Single Centre Experience.

Authors:  Daina Liekiene; Laurynas Bezuska; Palmyra Semeniene; Rasa Cypiene; Virgilijus Lebetkevicius; Virgilijus Tarutis; Jurate Barysiene; Kestutis Rucinskas; Vytautas Sirvydis
Journal:  Medicina (Kaunas)       Date:  2019-09-19       Impact factor: 2.430

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.